Skip to main content

Table 1 Baseline characteristics among kidney transplant recipients from donors > 65 years and ≤ 65 years

From: Early outcomes of kidney transplantation from elderly donors after circulatory death (GEODAS study)

  Donor ≤65 years
(n = 426)
Donor > 65 years
(n = 135)
p-value
Recipient characteristics
 Age (years, mean (SD)) 53.7 (11.4) 65.8 (8.8) < 0.001
  Age > 65 years (%) 14.6 61.3 < 0.001
 Female Gender (%) 30.1 35.6 0.23
 Black Race (%) 1.4 0.7 0.5
 Diabetes mellitus (%) 26.1 51.4 < 0.001
 Previous cardiovascular eventa (%) 7.8 20.7 < 0.001
Cause of end-stage renal disease (%)
Hypertensive nephropathy 12.4 11.9  
Diabetic nephropathy 11.3 22.2  
Glomerulonephritis 19.0 12.6  
Interstitial 11.0 11.9 0.03
Polycystic 15.3 11.1  
Others 6.7 5.9  
Unknown 19.7 23.7  
Previous renal replacement therapy (%)
Hemodialysis 73.1 83.0  
Peritoneal Dialysis 21.0 14.8 0.05
Preemptive kidney transplant 5.9 2.2  
 Dialysis vintage (years, median [IQR]) 1.1 [2.0–3.6] 1.3 [2.6–4.0] 0.08
 Patients with previous kidney transplant (%) 8.4 7.4 0.7
 Donor characteristics
 Age (years, mean (SD)) 52.7 (9.1) 72.0 (4.9) < 0.001
 Female Gender (%) 26.3 45.9 < 0.001
 Expanded criteria donors (%) 29.3 100 < 0.001
 Stroke as Cause of death (%) 49.2 67.8 < 0.001
 Transplant characteristics
 Number of HLA mismatches (median (IQR)) 4 [3–5] 4 [3–5] 0.003
 Cold ischemia time (hours, median (IQR)) 11 [7–18] 9.5 [7–16.5] 0.326
 Warm ischemia time (min, median (IQR)) 23.5 [15–36.5] 26 [16–35] 0.901
 Induction treatment (Thymoglobulin, %) 70.7 57 0.003
 Maintenance (Tacrolimus+MPA + steroids, %) 82.9 80.7 0.57
 Time of follow-up (years, median [IQR]) 1.6 [0.9–2.6] 1.1 [0.7–1.8] < 0.001
  1. SD standard deviation, MPA mycophenolic acid, IQR interquartile range
  2. aAcute myocardial infarction, stroke or peripheral vascular disease (amputation)